Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

METHYLENE BLEU LIQ 1% 1 % — DIN 00050466

METHYLENE BLUE : 1 % · LABORATOIRE ATLAS INC · LIQUID · wholesale supply in Canada

Health Canada status: MARKETED

What is METHYLENE BLEU LIQ 1%?

METHYLENE BLEU LIQ 1% 1 % contains METHYLENE BLUE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00050466, held by LABORATOIRE ATLAS INC, supplied as LIQUID for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Dec-1951. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Is there a generic Methylthionine in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

2 holders have a Canadian DIN containing Methylthionine, across 2 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
LABORATOIRE ATLAS INC11METHYLENE BLEU LIQ 1%Sourceable in Canada
ROUGIER PHARMA DIVISION OF RATIOPHARM INC10METHYLENE BLUE SOLUTION 1%No marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label1 %
Dosage formLIQUID
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceMethylthionine
ATC codeV04CG05
AHFS class92:00.00
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00050466
DIN (unpadded, as printed on some documents)50466
Brand nameMETHYLENE BLEU LIQ 1%
Generic / active ingredientMETHYLENE BLUE : 1 %
Market authorization holderLABORATOIRE ATLAS INC
Health Canada scheduleNON-PRESCRIPTION DRUGS
ATC codeV04CG05
ATC anatomical main groupV — Various
ATC therapeutic subgroupV04CG
Current statusMARKETED
Status date31-Dec-1951
Original market date1951-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

1 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
METHYLENE BLUE SOLUTION 1%1 %LIQUIDROUGIER PHARMA DIVISION OF RATIOPHARM INCCANCELLED POST MARKET00524476

2 · Same class — other molecules in ATC V04CG

MoleculeCanadian brandsDINsMarketedSourceable
MethylthionineMETHYLENE BLEU LIQ 1% · METHYLENE BLUE SOLUTION 1%21Yes
HistamineHISTAMINE PHOSPHATE INJECTION USP LIQ SC · HISTAMINE PHOSPHATE INJECTION USP, 1MG/ML20Not in Canada
PentagastrinPEPTAVLON LIQ INJ 0.25MG/ML10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC V04C

ATC subgroupMoleculesDINsMarketed
V04CXIndocyanine Green · Other Diagnostic Agents5916
V04CLTests For Allergic Diseases108
V04CCSincalide32
V04CDTests For Pituitary Function11
V04CFTuberculin51
V04CMGonadorelin50
V04CHAminohippuric Acid · Indigo Carmine20
V04CAGlucose60

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is METHYLENE BLEU LIQ 1% called?

Also recorded in Canada as: 10 ML methylene blue 5 MG/ML Injection [Provayblue] (US), 2 ML methylene blue 5 MG/ML Injection [Provayblue] (US), 1 ML methylene blue 10 MG/ML Injection (US), 10 ML methylene blue 10 MG/ML Injection (US), 10 ML methylene blue 5 MG/ML Injection (US), methylene blue 65 MG Oral Tablet (US), methylene blue 20 MG/ML Topical Solution (US), 2 ML methylene blue 5 MG/ML Injection (US), methylene blue 10 MG/ML Oral Solution (US), 2 ML methylene blue 10 MG/ML Prefilled Syringe (US), 10 ML methylene blue 5 MG/ML Prefilled Syringe (US), ACRIFLAVINE HYDROCHLORIDE, GENTIAN VIOLET, MALACHITE GREEN OXALATE, METHYLENE BLUE (US), ACRIFLAVINE HYDROCHLORIDE, METHYL ORANGE, ETHACRIDINE LACTATE, METHYLENE BLUE ANHYDROUS (US), ARTHCAL 1% METHYLENE BLUE (US), COPPER SULFATE PENTAHYDRATE, ETHACRIDINE LACTATE, METHYLENE BLUE ANHYDROUS (US).

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for METHYLENE BLEU LIQ 1%

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00050466. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.